Publication | Open Access

FAIRLANE, a double-blind placebo-controlled randomized phase II trial of neoadjuvant ipatasertib plus paclitaxel for early triple-negative breast cancer

Breast OncologyPhase Ii TrialMedicinePharmacologyClinical TrialsBreast CancerCancer TreatmentOncologyMolecular Oncology